These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 302112)

  • 1. Obtaining, evaluation and clinical application of antileukemic antilymphocyte globulin (ALLG) in the treatment of chronic lymphatic leukemia.
    Bratkowska-Seniów B; Dziedzic J; Kaniak T; Sobolewska B; Stumpf A; Wahl-Mugeńska M; Gieldanowski J; Lisowski J; Ludwikowska A; Szymaniec S; Teodorczyk J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):349-65. PubMed ID: 302112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia].
    Jasser S; Pawelski S; Skowrońska H; Tupalska B; Brühlowa A
    Acta Haematol Pol; 1971; 2(1):17-25. PubMed ID: 5170673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphopenia caused by antilymphocyte serum in chronic lymphatic leukemia].
    Pfisterer H; Michlmayr G; Meinzel E; Bolland H; Tsirimbas AD; Hornung B; Ruppelt W; Stich W
    Dtsch Med Wochenschr; 1968 Nov; 93(45):2159-61. PubMed ID: 5683957
    [No Abstract]   [Full Text] [Related]  

  • 4. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 5. [On chronic lymphatic leukemia and its therapy: study of 40 cases].
    Baccarani M; Tura S; Ricci Bitti ML; Storti E; Gugliotta L; Ricci P; Lauria F; Bagnara GP; Staffa C; Pascucci E
    G Clin Med; 1970 Oct; 51(10):764-84. PubMed ID: 4108784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of heterologous antilymphocyte globulin in chronic lymphoid leukemia].
    Pfisterer H; Lani K; Demmler K; Thierfelder S; Fateh-Moghadam A; Land W; Brendel W; Stich W
    Dtsch Med Wochenschr; 1971 Sep; 96(37):1468 passim. PubMed ID: 5105950
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic lymphatic leukemia: disorders of lymphocyte kinetics. Pathophysiological aspects and therapeutic consideration].
    Bremer K
    Dtsch Med Wochenschr; 1975 May; 100(22):1250-5. PubMed ID: 1132340
    [No Abstract]   [Full Text] [Related]  

  • 8. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of antilymphocyte globulin in the treatment of rheumatoid arthritis].
    Iannotta F; Fantini F; Colombo B
    Minerva Med; 1974 Jan; 65(5):241-8. PubMed ID: 4856472
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical use of antilymphocyte globulin (ALG) (author's transl)].
    Brendel W; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M
    Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of chronic lymphocytic leukemia.
    Silver RT
    Semin Hematol; 1969 Oct; 6(4):344-56. PubMed ID: 4900651
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 15. [The comparative efficacy of splenectomy and antilymphocyte globulin therapy in patients with aplastic anemia].
    Savchenko VG; Mikhaĭlova EA; Liubimova LS; Turbina NS; Ustinova EN; Mendeleeva LP; Zakharov GN; Askarov TU
    Ter Arkh; 1990; 62(7):76-81. PubMed ID: 2251670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabbit anti T-lymphocyte globulin induces apoptosis in peripheral blood mononuclear cell compartments and leukemia cells, while hematopoetic stem cells are apoptosis resistant.
    Grüllich C; Ziegler C; Finke J
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):173-82. PubMed ID: 19167677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunodepressive and immunostimulant effectiveness of bovine antilymphocyte gamma globulin for humans].
    Antonenko VT; Timchenko AS
    Fiziol Zh; 1976; 22(5):651-5. PubMed ID: 789121
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-human lymphocyte globulin: Pressimmune.
    Drug Ther Bull; 1976 Dec; 14(25):98-100. PubMed ID: 1087603
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.